2023-08-132024-08-312024-08-31false15067277OWLISTIC THERAPIES LIMITED2025-03-2796040falseiso4217:GBPxbrli:pure150672772023-08-13150672772024-08-31150672772023-08-132024-08-31150672772023-08-12150672772023-08-12150672772023-08-122023-08-1215067277bus:SmallEntities2023-08-132024-08-3115067277bus:AuditExempt-NoAccountantsReport2023-08-132024-08-3115067277bus:FullAccounts2023-08-132024-08-3115067277bus:PrivateLimitedCompanyLtd2023-08-132024-08-3115067277core:WithinOneYear2024-08-3115067277core:AfterOneYear2024-08-3115067277core:WithinOneYear2023-08-1215067277core:AfterOneYear2023-08-1215067277core:ShareCapital2024-08-3115067277core:SharePremium2024-08-3115067277core:RevaluationReserve2024-08-3115067277core:OtherReservesSubtotal2024-08-3115067277core:RetainedEarningsAccumulatedLosses2024-08-3115067277core:ShareCapital2023-08-1215067277core:SharePremium2023-08-1215067277core:RevaluationReserve2023-08-1215067277core:OtherReservesSubtotal2023-08-1215067277core:RetainedEarningsAccumulatedLosses2023-08-1215067277core:LandBuildings2024-08-3115067277core:PlantMachinery2024-08-3115067277core:Vehicles2024-08-3115067277core:FurnitureFittings2024-08-3115067277core:OfficeEquipment2024-08-3115067277core:NetGoodwill2024-08-3115067277core:IntangibleAssetsOtherThanGoodwill2024-08-3115067277core:ListedExchangeTraded2024-08-3115067277core:UnlistedNon-exchangeTraded2024-08-3115067277core:LandBuildings2023-08-1215067277core:PlantMachinery2023-08-1215067277core:Vehicles2023-08-1215067277core:FurnitureFittings2023-08-1215067277core:OfficeEquipment2023-08-1215067277core:NetGoodwill2023-08-1215067277core:IntangibleAssetsOtherThanGoodwill2023-08-1215067277core:ListedExchangeTraded2023-08-1215067277core:UnlistedNon-exchangeTraded2023-08-1215067277core:LandBuildings2023-08-132024-08-3115067277core:PlantMachinery2023-08-132024-08-3115067277core:Vehicles2023-08-132024-08-3115067277core:FurnitureFittings2023-08-132024-08-3115067277core:OfficeEquipment2023-08-132024-08-3115067277core:NetGoodwill2023-08-132024-08-3115067277core:IntangibleAssetsOtherThanGoodwill2023-08-132024-08-3115067277core:ListedExchangeTraded2023-08-132024-08-3115067277core:UnlistedNon-exchangeTraded2023-08-132024-08-3115067277core:MoreThanFiveYears2023-08-132024-08-3115067277core:Non-currentFinancialInstruments2024-08-3115067277core:Non-currentFinancialInstruments2023-08-1215067277dpl:CostSales2023-08-132024-08-3115067277dpl:DistributionCosts2023-08-132024-08-3115067277core:LandBuildings2023-08-132024-08-3115067277core:PlantMachinery2023-08-132024-08-3115067277core:Vehicles2023-08-132024-08-3115067277core:FurnitureFittings2023-08-132024-08-3115067277core:OfficeEquipment2023-08-132024-08-3115067277dpl:AdministrativeExpenses2023-08-132024-08-3115067277core:NetGoodwill2023-08-132024-08-3115067277core:IntangibleAssetsOtherThanGoodwill2023-08-132024-08-3115067277dpl:GroupUndertakings2023-08-132024-08-3115067277dpl:ParticipatingInterests2023-08-132024-08-3115067277dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-132024-08-3115067277core:ListedExchangeTraded2023-08-132024-08-3115067277dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-132024-08-3115067277core:UnlistedNon-exchangeTraded2023-08-132024-08-3115067277dpl:CostSales2023-08-122023-08-1215067277dpl:DistributionCosts2023-08-122023-08-1215067277core:LandBuildings2023-08-122023-08-1215067277core:PlantMachinery2023-08-122023-08-1215067277core:Vehicles2023-08-122023-08-1215067277core:FurnitureFittings2023-08-122023-08-1215067277core:OfficeEquipment2023-08-122023-08-1215067277dpl:AdministrativeExpenses2023-08-122023-08-1215067277core:NetGoodwill2023-08-122023-08-1215067277core:IntangibleAssetsOtherThanGoodwill2023-08-122023-08-1215067277dpl:GroupUndertakings2023-08-122023-08-1215067277dpl:ParticipatingInterests2023-08-122023-08-1215067277dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-122023-08-1215067277core:ListedExchangeTraded2023-08-122023-08-1215067277dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-122023-08-1215067277core:UnlistedNon-exchangeTraded2023-08-122023-08-1215067277core:NetGoodwill2024-08-3115067277core:IntangibleAssetsOtherThanGoodwill2024-08-3115067277core:LandBuildings2024-08-3115067277core:PlantMachinery2024-08-3115067277core:Vehicles2024-08-3115067277core:FurnitureFittings2024-08-3115067277core:OfficeEquipment2024-08-3115067277core:AfterOneYear2024-08-3115067277core:WithinOneYear2024-08-3115067277core:ListedExchangeTraded2024-08-3115067277core:UnlistedNon-exchangeTraded2024-08-3115067277core:ShareCapital2024-08-3115067277core:SharePremium2024-08-3115067277core:RevaluationReserve2024-08-3115067277core:OtherReservesSubtotal2024-08-3115067277core:RetainedEarningsAccumulatedLosses2024-08-3115067277core:NetGoodwill2023-08-1215067277core:IntangibleAssetsOtherThanGoodwill2023-08-1215067277core:LandBuildings2023-08-1215067277core:PlantMachinery2023-08-1215067277core:Vehicles2023-08-1215067277core:FurnitureFittings2023-08-1215067277core:OfficeEquipment2023-08-1215067277core:AfterOneYear2023-08-1215067277core:WithinOneYear2023-08-1215067277core:ListedExchangeTraded2023-08-1215067277core:UnlistedNon-exchangeTraded2023-08-1215067277core:ShareCapital2023-08-1215067277core:SharePremium2023-08-1215067277core:RevaluationReserve2023-08-1215067277core:OtherReservesSubtotal2023-08-1215067277core:RetainedEarningsAccumulatedLosses2023-08-1215067277core:NetGoodwill2023-08-1215067277core:IntangibleAssetsOtherThanGoodwill2023-08-1215067277core:LandBuildings2023-08-1215067277core:PlantMachinery2023-08-1215067277core:Vehicles2023-08-1215067277core:FurnitureFittings2023-08-1215067277core:OfficeEquipment2023-08-1215067277core:AfterOneYear2023-08-1215067277core:WithinOneYear2023-08-1215067277core:ListedExchangeTraded2023-08-1215067277core:UnlistedNon-exchangeTraded2023-08-1215067277core:ShareCapital2023-08-1215067277core:SharePremium2023-08-1215067277core:RevaluationReserve2023-08-1215067277core:OtherReservesSubtotal2023-08-1215067277core:RetainedEarningsAccumulatedLosses2023-08-1215067277core:AfterOneYear2023-08-132024-08-3115067277core:WithinOneYear2023-08-132024-08-3115067277core:Non-currentFinancialInstrumentscore:CostValuation2023-08-132024-08-3115067277core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-132024-08-3115067277core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-132024-08-3115067277core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-132024-08-3115067277core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-132024-08-3115067277core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-132024-08-3115067277core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-132024-08-3115067277core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-132024-08-3115067277core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-132024-08-3115067277core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3115067277core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3115067277core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3115067277core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3115067277core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3115067277core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3115067277core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3115067277core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3115067277core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3115067277core:Non-currentFinancialInstrumentscore:CostValuation2023-08-1215067277core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-1215067277core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-1215067277core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-1215067277core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-1215067277core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-1215067277core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-1215067277core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-1215067277core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-1215067277bus:Director12023-08-132024-08-31

OWLISTIC THERAPIES LIMITED

Registered Number
15067277
(England and Wales)

Unaudited Financial Statements for the Period ended
31 August 2024

OWLISTIC THERAPIES LIMITED
Company Information
for the period from 13 August 2023 to 31 August 2024

Director

DE SALGADO SALGADO, Henrique

Registered Address

Martinique House
Hampshire Road
Bordon
GU35 0HJ

Registered Number

15067277 (England and Wales)
OWLISTIC THERAPIES LIMITED
Balance Sheet as at
31 August 2024

Notes

2024

£

£

Fixed assets
Tangible assets31,881
1,881
Current assets
Stocks43,000
Debtors5277
Cash at bank and on hand158
3,435
Creditors amounts falling due within one year6(1,351)
Net current assets (liabilities)2,084
Total assets less current liabilities3,965
Creditors amounts falling due after one year7(5,276)
Net assets(1,311)
Capital and reserves
Called up share capital4
Share premium24
Profit and loss account(1,339)
Shareholders' funds(1,311)
The financial statements were approved and authorised for issue by the Director on 27 March 2025, and are signed on its behalf by:
DE SALGADO SALGADO, Henrique
Director
Registered Company No. 15067277
OWLISTIC THERAPIES LIMITED
Notes to the Financial Statements
for the period ended 31 August 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
The ability of the company to continue to trade is dependant upon the continuing support of the director. The director is of the opinion that the company will continue to receive this support and on this basis considers it appropriate to prepare the accounts on a going concern basis. The financial statements do not include any adjustments that would result in the withdrawal of this support.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Office Equipment25
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

2024
Average number of employees during the year0
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions2,2022,202
At 31 August 242,2022,202
Depreciation and impairment
Charge for year321321
At 31 August 24321321
Net book value
At 31 August 241,8811,881
At 12 August 23--
4.Stocks

2024

£
Finished goods3,000
Total3,000
5.Debtors: amounts due within one year

2024

£
Prepayments and accrued income277
Total277
6.Creditors: amounts due within one year

2024

£
Bank borrowings and overdrafts391
Accrued liabilities and deferred income960
Total1,351
7.Creditors: amounts due after one year

2024

£
Bank borrowings and overdrafts5,276
Total5,276
8.Related party transactions
At the year end, the company owed Gareth Turner the partner of the director £5,276.39. The loan is repayable on demand. There is no interest on this loan.